Difficulty: Medium
Average Score: 73%
Practice
A 61-year-old man with Parkinson's disease on bromocriptine dies suddenly of a cardiopulmonary arrest. Autopsy is performed at the request of the family. Sectioning of the lungs in this patient is most likely to reveal which of the following findings?
Correct answer
C
Rationale
The correct answer is C) Pulmonary embolus. In this case, the patient's sudden cardiopulmonary arrest could be attributed to a pulmonary embolus, which is a common complication in patients with Parkinson's disease due to their immobility and increased risk of blood clots. Bromocriptine, a dopamine agonist used in Parkinson's disease, can also increase the risk of clot formation.
Option A) Adenocarcinoma is less likely in this scenario as the patient's cause of death was sudden cardiopulmonary arrest, not typically associated with adenocarcinoma. Option B) Pneumonia is less likely as it usually presents with symptoms such as cough, fever, and chest pain, which are not described in the case. Option D) Pulmonary fibrosis is also less likely as it is a chronic condition that develops over time, unlike the sudden onset described in the case.
This case highlights the importance of understanding the cardiovascular pharmacology of medications in relation to patient outcomes and the potential complications that can arise. It also underscores the need for healthcare providers to be vigilant in monitoring and managing the cardiovascular risks associated with certain medications and underlying conditions.
Option A) Adenocarcinoma is less likely in this scenario as the patient's cause of death was sudden cardiopulmonary arrest, not typically associated with adenocarcinoma. Option B) Pneumonia is less likely as it usually presents with symptoms such as cough, fever, and chest pain, which are not described in the case. Option D) Pulmonary fibrosis is also less likely as it is a chronic condition that develops over time, unlike the sudden onset described in the case.
This case highlights the importance of understanding the cardiovascular pharmacology of medications in relation to patient outcomes and the potential complications that can arise. It also underscores the need for healthcare providers to be vigilant in monitoring and managing the cardiovascular risks associated with certain medications and underlying conditions.